Study: 17% of HCV patients have contraindication to therapy

01/28/2013 | Medscape (free registration)

A study found 17.3% of patients with chronic hepatitis C had a contraindication to pegylated interferon and ribavirin therapy, but most were treatable or transient. Bipolar disorders, anemia and pregnancy were the most common contraindications, according to researchers from State University of New York in Buffalo. Those with contraindications tended to be white, younger, female, unmarried and covered by public insurance.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC